Spironolactone Tablet, Film Coated
Product Images NDC 71335-0304

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-0304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713350304)

Label (Lbl713350304)
Spironolactone 100 mg tablet label packaged by Bryant Ranch Prepack in Burbank, CA. The label notes the product is an orange round tablet and compares it to Aldactone 100 mg by Intas Pharmaceuticals Limited. It includes storage instructions to keep at room temperature (20°-25°C) and keep out of reach of children. The NDC is 71335-0304.*
FDA Label Image

Figure 1 (Spironolactone Figure 1)

Figure 1 (Spironolactone Figure 1)
A Kaplan-Meier survival curve comparing Spironolactone (100 mg) and placebo over time in months. The y-axis shows probability, and the x-axis shows months up to 48. The graph demonstrates distinct probability trends for 822 Spironolactone subjects and 841 placebo subjects, with a log-rank p-value less than 0.001.*
FDA Label Image

Figure 2 (Spironolactone Figure 2)

Figure 2 (Spironolactone Figure 2)
A forest plot showing the hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups from a clinical study comparing Spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium level, digoxin use, ACE inhibitor use, and beta blocker use. The plot visually indicates whether Spironolactone or placebo is favored for each subgroup.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure diagram of the active ingredient Spironolactone, showing its steroid backbone with labeled carbon rings and functional groups including lactone and thioacetyl moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.